BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,853,000 | -48.5% | 45,333 | -50.4% | 0.00% | -40.0% |
| Q2 2022 | $13,312,000 | +35.9% | 91,363 | +10.6% | 0.01% | +66.7% |
| Q1 2022 | $9,794,000 | +33.6% | 82,599 | +55.3% | 0.00% | +50.0% |
| Q4 2021 | $7,330,000 | -28.9% | 53,186 | -28.3% | 0.00% | -33.3% |
| Q3 2021 | $10,303,000 | +538.0% | 74,176 | +346.0% | 0.00% | +200.0% |
| Q2 2021 | $1,615,000 | +42.2% | 16,633 | +0.0% | 0.00% | – |
| Q1 2021 | $1,136,000 | -50.8% | 16,625 | -38.3% | 0.00% | -100.0% |
| Q4 2020 | $2,311,000 | +20.1% | 26,960 | -8.9% | 0.00% | 0.0% |
| Q3 2020 | $1,925,000 | – | 29,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |